Literature DB >> 10227685

X-linked adrenoleukodystrophy: genes, mutations, and phenotypes.

K D Smith1, S Kemp, L T Braiterman, J F Lu, H M Wei, M Geraghty, G Stetten, J S Bergin, J Pevsner, P A Watkins.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is a complex and perplexing neurodegenerative disorder. The metabolic abnormality, elevated levels of very long-chain fatty acids in tissues and plasma, and the biochemical defect, reduced peroxisomal very long-chain acyl-CoA synthetase (VLCS) activity, are ubiquitous features of the disease. However, clinical manifestations are highly variable with regard to time of onset, site of initial pathology and rate of progression. In addition, the abnormal gene in X-ALD is not the gene for VLCS. Rather, it encodes a peroxisomal membrane protein with homology to the ATP-binding cassette (ABC) transmembrane transporter superfamily of proteins. The X-ALD protein (ALDP) is closely related to three other peroxisomal membrane ABC proteins. In this report we summarize all known X-ALD mutations and establish the lack of an X-ALD genotype/phenotype correlation. We compare the evolutionary relationships among peroxisomal ABC proteins, demonstrate that ALDP forms homodimers with itself and heterodimers with other peroxisomal ABC proteins and present cDNA complementation studies suggesting that the peroxisomal ABC proteins have overlapping functions. We also establish that there are at least two peroxisomal VLCS activities, one that is ALDP dependent and one that is ALDP independent. Finally, we discuss variable expression of the peroxisomal ABC proteins and ALDP independent VLCS in relation to the variable clinical presentations of X-ALD.

Entities:  

Mesh:

Year:  1999        PMID: 10227685     DOI: 10.1023/a:1022535930009

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  72 in total

1.  Characterization and analysis of conserved motifs in a peroxisomal ATP-binding cassette transporter.

Authors:  N Shani; A Sapag; D Valle
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

2.  Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.

Authors:  L T Braiterman; S Zheng; P A Watkins; M T Geraghty; G Johnson; M C McGuinness; A B Moser; K D Smith
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

3.  Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.

Authors:  I Singh; A E Moser; H W Moser; Y Kishimoto
Journal:  Pediatr Res       Date:  1984-03       Impact factor: 3.756

4.  Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.

Authors:  A Braun; H Ambach; S Kammerer; B Rolinski; S Stöckler; W Rabl; J Gärtner; S Zierz; A A Roscher
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

5.  Peroxisomal fatty acid beta-oxidation in HepG2 cells.

Authors:  P A Watkins; E V Ferrell; J I Pedersen; G Hoefler
Journal:  Arch Biochem Biophys       Date:  1991-09       Impact factor: 4.013

6.  Purification and properties of rat liver peroxisomal very-long-chain acyl-CoA synthetase.

Authors:  Y Uchida; N Kondo; T Orii; T Hashimoto
Journal:  J Biochem       Date:  1996-03       Impact factor: 3.387

7.  Topology of the hydrophobic membrane-bound components of the histidine periplasmic permease. Comparison with other members of the family.

Authors:  R E Kerppola; G F Ames
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

8.  Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome.

Authors:  J Gärtner; H Moser; D Valle
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

9.  Molecular analysis of X-linked adrenoleukodystrophy patients.

Authors:  T Yasutake; T Yamada; H Furuya; N Shinnoh; I Goto; T Kobayashi
Journal:  J Neurol Sci       Date:  1995-07       Impact factor: 3.181

10.  Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.

Authors:  R J Wanders; C W van Roermund; M J van Wijland; R B Schutgens; H van den Bosch; A W Schram; J M Tager
Journal:  Biochem Biophys Res Commun       Date:  1988-06-16       Impact factor: 3.575

View more
  39 in total

Review 1.  Genetics of the development and function of the adrenal cortex.

Authors:  K L Parker; B P Schimmer
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 3.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

4.  Novel mutation in ATP-binding domain of ABCD1 gene in adrenoleukodystrophy.

Authors:  Neeraj Kumar; Krishna K Taneja; Atul Kumar; Deepti Nayar; Bhupesh Taneja; Satindra Aneja; Madhuri Behari; Veena Kalra; Surendra K Bansal
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

5.  A Novel Double Mutation in the ABCD1 Gene in a Patient with X-linked Adrenoleukodystrophy: Analysis of the Stability and Function of the Mutant ABCD1 Protein.

Authors:  Masashi Morita; Junpei Kobayashi; Kozue Yamazaki; Kosuke Kawaguchi; Ayako Honda; Kenji Sugai; Nobuyuki Shimozawa; Reiji Koide; Tsuneo Imanaka
Journal:  JIMD Rep       Date:  2013-02-12

Review 6.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 7.  Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases?

Authors:  Doris Kretzschmar
Journal:  Invert Neurosci       Date:  2005-10-24

8.  SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes.

Authors:  Rebecca Deering Brose; Dimitri Avramopoulos; Kirby D Smith
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

9.  Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal β-Oxidation of Very-long-chain Fatty Acids.

Authors:  Yuichi Yagita; Kyoko Shinohara; Yuichi Abe; Keiko Nakagawa; Mohammed Al-Owain; Fowzan S Alkuraya; Yukio Fujiki
Journal:  J Biol Chem       Date:  2016-11-29       Impact factor: 5.157

10.  Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase.

Authors:  Peter Fraisl; Sonja Forss-Petter; Mihaela Zigman; Johannes Berger
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.